Company Cell MedX Corp OTC Bulletin Board
Equities
US15115X1072
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
15/04 | Cell MedX Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
12/03 | Cell MedX Corp. announced that it has received $0.075 million in funding | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Monthly Subscriptions
58.8
%
| 0 | 60.6 % | 0 | 58.8 % | -55.85% |
eBalance Devices
41.2
%
| 0 | 39.4 % | 0 | 41.2 % | -52.33% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -54.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Yanika Silina
DFI | Director of Finance/CFO | 46 | 24/14/24 |
George Adams
CHM | Chairman | 76 | 23/18/23 |
Joao da Costa
BRD | Director/Board Member | 59 | 08/20/08 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 27/22/27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 27/22/27 |
Joao da Costa
BRD | Director/Board Member | 59 | 08/20/08 |
George Adams
CHM | Chairman | 76 | 23/18/23 |
Amir Vahabzadeh
BRD | Director/Board Member | 55 | 12/12 |
Yanika Silina
DFI | Director of Finance/CFO | 46 | 24/14/24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 297,236,373 | 60,447,694 ( 20.34 %) | 0 | 20.34 % |
Company contact information
![address Cell MedX Corp](https://cdn.zonebourse.com/static/address/21163003.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+25.96% | 46.56B | |
+44.87% | 41.67B | |
-0.51% | 41.16B | |
+34.83% | 32.4B | |
+21.29% | 28.18B | |
-6.35% | 28.1B | |
+49.62% | 14.52B | |
+47.76% | 13.74B | |
+1.79% | 12.17B |
- Stock Market
- Equities
- CMXC Stock
- Stock
- Company Cell MedX Corp